Skip to main content
logo
Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.61
+0.29 (3.89%)
At close: Jul 10, 2026, 4:00 PM EDT
7.61
0.00 (0.00%)
After-hours: Jul 10, 2026, 4:10 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
The Discovery, Development and Commercialization of Novel Therapeutics
6.44M29.62M46.80M140.73M235.31M
The Discovery, Development and Commercialization of Novel Therapeutics Growth
-78.26%-36.71%-66.74%-40.19%33.46%
Total
6.44M29.62M46.80M140.73M235.31M
Total Growth
-78.26%-36.71%-66.74%-40.19%33.46%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
-26.11M12.96M12.52M46.12M
United States Growth
-101.48%3.53%-72.86%-29.24%
Europe
5.64M6.27M9.55M33.82M131.24M
Europe Growth
-10.00%-34.34%-71.77%-74.23%631.00%
Japan
797.00K-2.85M15.87M9.76M2.31M
Japan Growth
--62.51%323.60%-88.37%
China
-91.00K8.43M84.63M55.64M
China Growth
--98.92%-90.04%52.10%-24.16%
Total
6.44M29.62M46.80M140.73M235.31M
Total Growth
-78.26%-36.71%-66.74%-40.19%33.46%